Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonke Svenson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Chemical Society Reviews|May 15, 2015
The dendrimer paradox--high medical expectations but poor clinical translationSonke Svenson
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 14, 2014
What nanomedicine in the clinic right now really forms nanoparticles?Sonke Svenson
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 4, 2008
Dendrimers as versatile platform in drug delivery applicationsSonke Svenson
Molecular Pharmaceutics|February 6, 2013
Theranostics: are we there yet?Sonke Svenson
Nanomedicine (London, England)|September 27, 2008
Dendrimers for enhanced drug solubilizationSonke Svenson, Abhay S Chauhan
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2011
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101Sonke Svenson, Marc Wolfgang, Jungyeon Hwang, et al.
Molecular Pharmaceutics|February 3, 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric NanopharmaceuticalSonke Svenson, Roy I Case, Roderick O Cole, et al.
Journal of Medicinal Chemistry|October 9, 2019
Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery PlatformChester A Metcalf, Sonke Svenson, Jungyeon Hwang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chemical Society Reviews|May 15, 2015
The dendrimer paradox--high medical expectations but poor clinical translationSonke Svenson
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 14, 2014
What nanomedicine in the clinic right now really forms nanoparticles?Sonke Svenson
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 4, 2008
Dendrimers as versatile platform in drug delivery applicationsSonke Svenson
Molecular Pharmaceutics|February 6, 2013
Theranostics: are we there yet?Sonke Svenson
Nanomedicine (London, England)|September 27, 2008
Dendrimers for enhanced drug solubilizationSonke Svenson, Abhay S Chauhan
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2011
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101Sonke Svenson, Marc Wolfgang, Jungyeon Hwang, et al.
Molecular Pharmaceutics|February 3, 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric NanopharmaceuticalSonke Svenson, Roy I Case, Roderick O Cole, et al.
Journal of Medicinal Chemistry|October 9, 2019
Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery PlatformChester A Metcalf, Sonke Svenson, Jungyeon Hwang, et al.
Pageof 1